Abstract
This study described the drug release, rheological (dynamic and flow) and textural / mechanical properties of a series of formulations composed of 15% w / w polymethylvinylether-co-maleic anhydride (PMVE-MA), 0-9% w / w polyvinylpyrrolidone (PVP) and containing 1-5% w / w tetracycline hydrochloride, designed for the treatment of periodontal disease. All formulations exhibited pseudoplastic flow with minimal thixotropy. Increasing the concentration of PVP sequentially increased the zero-rate viscosity (derived from the Cross model) and the hardness and compressibility of the formulations (derived from texture profile analysis). These affects may be accredited to increased polymer entanglement and, in light of the observed synergy between the two polymers with respect to their textural and rheological properties, interaction between PVP and PMVEMA. Increasing the concentration of PVP increased the storage and loss moduli yet decreased the loss tangent of all formulations, indicative of increased elastic behaviour. Synergy between the two polymers with respect to their viscoelastic properties was observed. Increased adhesiveness, associated with increased concentrations of PVP was ascribed to the increasing bioadhesion and tack of the formulations. The effect of increasing drug concentration on the rheological and textural properties was dependent on PVP concentration. At lower concentrations (0, 3% w / w) no effect was observed whereas, in the presence of 9% w / w PVP, increasing drug concentration increased formulation elasticity, zero rate viscosity, hardness and compressibility. These observations were ascribed to the greater mass of suspended drug in formulations containing the highest concentration of PVP. Drug release from formulations containing 6 and 9% PVP (and 5% w / w drug) was prolonged and swelling / diffusion controlled. Based on the drug release, rheological and textural properties, it is suggested that the formulation containing 15% w / w PMVE-MA, 6% w / w PVP and tetracycline hydrochloride (5% w / w) may be useful for the treatment of periodontal disease.
Keywords: Tetracycline, bioadhesion, Polymer Networks Designed, PVP and PMVEMA
Current Drug Delivery
Title: Formulation and Characterisation of Tetracycline-Containing Bioadhesive Polymer Networks Designed for the Treatment of Periodontal Disease
Volume: 1 Issue: 1
Author(s): David S. Jones, Michelle S. Lawlor and A. David Woolfson
Affiliation:
Keywords: Tetracycline, bioadhesion, Polymer Networks Designed, PVP and PMVEMA
Abstract: This study described the drug release, rheological (dynamic and flow) and textural / mechanical properties of a series of formulations composed of 15% w / w polymethylvinylether-co-maleic anhydride (PMVE-MA), 0-9% w / w polyvinylpyrrolidone (PVP) and containing 1-5% w / w tetracycline hydrochloride, designed for the treatment of periodontal disease. All formulations exhibited pseudoplastic flow with minimal thixotropy. Increasing the concentration of PVP sequentially increased the zero-rate viscosity (derived from the Cross model) and the hardness and compressibility of the formulations (derived from texture profile analysis). These affects may be accredited to increased polymer entanglement and, in light of the observed synergy between the two polymers with respect to their textural and rheological properties, interaction between PVP and PMVEMA. Increasing the concentration of PVP increased the storage and loss moduli yet decreased the loss tangent of all formulations, indicative of increased elastic behaviour. Synergy between the two polymers with respect to their viscoelastic properties was observed. Increased adhesiveness, associated with increased concentrations of PVP was ascribed to the increasing bioadhesion and tack of the formulations. The effect of increasing drug concentration on the rheological and textural properties was dependent on PVP concentration. At lower concentrations (0, 3% w / w) no effect was observed whereas, in the presence of 9% w / w PVP, increasing drug concentration increased formulation elasticity, zero rate viscosity, hardness and compressibility. These observations were ascribed to the greater mass of suspended drug in formulations containing the highest concentration of PVP. Drug release from formulations containing 6 and 9% PVP (and 5% w / w drug) was prolonged and swelling / diffusion controlled. Based on the drug release, rheological and textural properties, it is suggested that the formulation containing 15% w / w PMVE-MA, 6% w / w PVP and tetracycline hydrochloride (5% w / w) may be useful for the treatment of periodontal disease.
Export Options
About this article
Cite this article as:
Jones S. David, Lawlor S. Michelle and Woolfson David A., Formulation and Characterisation of Tetracycline-Containing Bioadhesive Polymer Networks Designed for the Treatment of Periodontal Disease, Current Drug Delivery 2004; 1 (1) . https://dx.doi.org/10.2174/1567201043480027
DOI https://dx.doi.org/10.2174/1567201043480027 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections
Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
Nanotechnology Based Chemotherapy for the treatment of Head & Neck Cancer
The escalating recurrence rates observed in Head and Neck cancer, particularly within the chemo-therapeutically treated cohort (50-60%), can be attributed to the non-selective nature of current anticancer drug delivery modalities. In this context, nanotechnology-based drug delivery systems emerge as a promising avenue for achieving precise localization of therapeutic agents to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Use of Nitric Oxide Synthase Inhibitors in Inflammatory Diseases: A Novel Class of Anti-Inflammatory Agents
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Anti-Inflammatory Approaches to Reduce Acute Cardiovascular Events: Not Only Benefits
Current Pharmaceutical Biotechnology Teeth: Small but Mighty and Mighty Important. A Comprehensive Review of Children’s Dental Health for Primary Care Clinicians
Current Pediatric Reviews Pharmacotherapy & Surgical Interventions Available for Obesity Management and Importance of Pancreatic Lipase Inhibitory Phytomolecules as Safer Anti-Obesity Therapeutics
Mini-Reviews in Medicinal Chemistry Meet Our Editorial Board Member:
Current Tissue Engineering (Discontinued) Polymer Particulates in Drug Delivery
Current Pharmaceutical Design On the Possible Relevance of Bottom-up Pathways in the Pathogenesis of Alzheimer’s Disease
Current Topics in Medicinal Chemistry Periodontal Muco-Adhesive Formulations for the Treatment of Infectious Periodontal Diseases
Current Drug Delivery Cysteine Protease Inhibitors: from Evolutionary Relationships to Modern Chemotherapeutic Design for the Treatment of Infectious Diseases
Current Protein & Peptide Science Dual Controlled Release, In Situ Gelling Periodontal Sol of Metronidazole Benzoate and Serratiopeptidase: Statistical Optimization and Mechanistic Evaluation
Current Drug Delivery Medicinal Use of Lincosamides and Microbial Resistance to Them
Anti-Infective Agents in Medicinal Chemistry Nanoemulsions for Improved Efficacy of Phytotherapeutics- A Patent Perspective
Recent Patents on Nanotechnology Allergen-Induced Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Adenotonsillar Disease
Recent Patents on Inflammation & Allergy Drug Discovery New Approaches to Target the Mycolic Acid Biosynthesis Pathway for the Development of Tuberculosis Therapeutics
Current Pharmaceutical Design Editorial [ Immune-Mediated Mechanisms in Atheroclerosis:Prevention and Treatment of Clinical Manifestations Executive Editor: Emilio Jirillo ]
Current Pharmaceutical Design Role of the Epithelial Cell Rests of Malassez in Periodontal Homeostasis and Regeneration - A Review
Current Stem Cell Research & Therapy Serum Microbial- and Host-Derived Markers of Periodontal Diseases: A Review
Current Medicinal Chemistry Production of Recombinant Proteins in Bacteria: The Inclusion Bodies Formation and their Use in Biomedicine
Recent Patents on Biomedical Engineering (Discontinued) Platelet-Rich Plasma Induces Mixed Osteogenic/Osteoclastogenic Phenotype in Osteosarcoma SaOS-2 Cells: Role of TGF-Beta
Current Pharmaceutical Biotechnology